High-grade serous ovarian carcinoma (HGSOC) represents the most common form of
epithelial ovarian carcinoma. The absence of specific symptoms leads to late-stage …

Ovarian cancer (OC) is the most lethal gynecological cancer in the developed world. Most
cases are diagnosed at late stage III-IV with a very low 5-year overall survival rate. Several …

Endometriosis is a painful gynecologic disease affecting one in ten reproductive aged
women worldwide. Few studies have correlated this symptomatology with biomarker levels …

Ovarian cancer is a fatal female reproductive cancer because it has no specific clinical
manifestations and effective screening methods in the early stage. When it is discovered, it is …

Abstract Background Cancer antigen 125 (CA125) is clinically used to monitor response to
therapy in ovarian cancer and has been proposed for use in detecting ovarian cancer. This …

The development of an electrochemical aptasensor for the detection of CA125 as an ovarian
cancer biomarker using gold nanostructures (GNs) modified electrodes is reported. The GNs …

Background To elucidate the mechanisms of thymic epithelial tumor (TET) canceration by
characterizing genomic mutations and signaling pathway alterations. Methods Primary …

Purpose Among healthy postmenopausal women, levels of CA125 and CA15. 3 are
influenced by demographic and reproductive factors, including race/ethnicity. In this study …

Background: We aimed to explore the risk factors of lung nodules and lung cancer in
physical examination population with low-dose multi-slice spiral CT (LDCT) screening, to …

Objectives In women with ovarian cancer, tumor features largely determine serum HE4 and
CA125 levels, but non-tumor factors may also influence levels and be better understood by …